Literature DB >> 15795526

SPL7013 gel as a topical microbicide for prevention of vaginal transmission of SHIV89.6P in macaques.

Yong-Hou Jiang1, Peter Emau, J Scott Cairns, Leon Flanary, William R Morton, Tom D McCarthy, Che-Chung Tsai.   

Abstract

SPL7013 is a dendrimer with a polyanionic outer surface that allows multiple interactions with target sites. It potently binds and blocks HIV-1 and chimeric simian/HIV-1 viruses (SHIVs) replication in vitro. Gels containing different concentrations of SPL7013 were used as topical microbicides in female pigtailed macaques (Macaca nemestrina) to study their ability to prevent vaginal transmission of SHIV(89,6P). On virus challenge, all untreated macaques (8/8) and seven of eight macaques treated with placebo gel were infected within 2 weeks postinfection (PI) and showed high plasma viremia and dramatic CD4(+) cell decline within 4 weeks PI. In contrast, 6/6 macaques, 5/6 macaques, and 2/6 macaques treated with 5% w/w (50 mg/ml), 3% w/w (30 mg/ml), and 1% w/w (10 mg/ml) SPL7013 gels, respectively, resisted viral challenge. The results showed that animals treated with SPL7013 showed a dose-dependent resistance to virus challenge. Neither SPL7013 nor placebo gels produced any adverse effects following the single application in the study. These results showed that 3-5% w/w SPL7013 gels were effective in blocking vaginal transmission of SHIV in macaques after single gel application followed by single virus challenge. These results suggest that SPL7013 gel may be a promising anti-HIV microbicide formulation for further evaluation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15795526     DOI: 10.1089/aid.2005.21.207

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  48 in total

Review 1.  The potential of HIV-1 nanotherapeutics: from in vitro studies to clinical trials.

Authors:  Upal Roy; Jesse Rodríguez; Paul Barber; José das Neves; Bruno Sarmento; Madhavan Nair
Journal:  Nanomedicine (Lond)       Date:  2015-09-24       Impact factor: 5.307

2.  Preclinical safety and efficacy assessments of dendrimer-based (SPL7013) microbicide gel formulations in a nonhuman primate model.

Authors:  D L Patton; Y T Cosgrove Sweeney; T D McCarthy; S L Hillier
Journal:  Antimicrob Agents Chemother       Date:  2006-05       Impact factor: 5.191

3.  Peptide- and saccharide-conjugated dendrimers for targeted drug delivery: a concise review.

Authors:  Jie Liu; Warren D Gray; Michael E Davis; Ying Luo
Journal:  Interface Focus       Date:  2012-03-21       Impact factor: 3.906

Review 4.  Targeting Trojan Horse leukocytes for HIV prevention.

Authors:  Deborah J Anderson; Joseph A Politch; Adam M Nadolski; Caitlin D Blaskewicz; Jeffrey Pudney; Kenneth H Mayer
Journal:  AIDS       Date:  2010-01-16       Impact factor: 4.177

5.  Olive oil based novel thermo-reversible emulsion hydrogels for controlled delivery applications.

Authors:  Vinay K Singh; Sowmya Ramesh; Kunal Pal; Arfat Anis; Dillip K Pradhan; Krishna Pramanik
Journal:  J Mater Sci Mater Med       Date:  2013-12-11       Impact factor: 3.896

Review 6.  Vaginal microbicides and the prevention of HIV transmission.

Authors:  Blayne Cutler; Jessica Justman
Journal:  Lancet Infect Dis       Date:  2008-11       Impact factor: 25.071

Review 7.  Nanovehicular intracellular delivery systems.

Authors:  Ales Prokop; Jeffrey M Davidson
Journal:  J Pharm Sci       Date:  2008-09       Impact factor: 3.534

8.  A randomized controlled trial of the safety of candidate microbicide SPL7013 gel when applied to the penis.

Authors:  Marcus Y Chen; Iona Y Millwood; Handan Wand; Mary Poynten; Matthew Law; John M Kaldor; Steve Wesselingh; Clare F Price; Laura J Clark; Jeremy R A Paull; Christopher K Fairley
Journal:  J Acquir Immune Defic Syndr       Date:  2009-04-01       Impact factor: 3.731

Review 9.  VivaGel (SPL7013 Gel): a candidate dendrimer--microbicide for the prevention of HIV and HSV infection.

Authors:  Richard Rupp; Susan L Rosenthal; Lawrence R Stanberry
Journal:  Int J Nanomedicine       Date:  2007

10.  RT-SHIV, an infectious CCR5-tropic chimeric virus suitable for evaluating HIV reverse transcriptase inhibitors in macaque models.

Authors:  Yonghou Jiang; Baoping Tian; Mohammed Saifuddin; Michael B Agy; Peter Emau; J Scott Cairns; Che-Chung Tsai
Journal:  AIDS Res Ther       Date:  2009-11-05       Impact factor: 2.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.